22 April 2023 - Health Canada has approved a new antibody drug to help protect babies from serious illness caused ...
6 April 2023 - This CADTH recommendation is a step towards public access to Rybrevant as a targeted therapy for ...
17 April 2023 - New treatment option for Canadians living with rare and serious X-chromosome linked congenital bleeding disorder ...
14 April 2023 - Indications under review include prevention of respiratory syncytial virus in infants from birth through 6 months ...
10 April 2023 - With this approval, approximately 30 children with two copies of the F508del mutation are eligible for ...
3 April 2023 - First and only therapy approved to treat this rare and debilitating genetic condition. ...
31 March 2023 - New formulation allows twice-daily dosing in patients with transfusional iron overload due to thalassaemia syndromes when ...
31 March 2023 - Mitsubishi Tanabe Pharma Canada is pleased to announce the company has entered into negotiations with the ...
23 March 2023 - Landmark ZUMA-7 study demonstrated patients on Yescarta were 2.5 times more likely to be alive at ...
23 March 2023 - All oral, once daily, fixed duration combination regimen authorised for first-line treatment of CLL. ...
25 March 2023 - Authorization is based on results from the Phase 1/2 NP30179 study, which demonstrated Columvi induced durable response ...
24 March 2023 - In the EFFISAYIL-1 trial, over half of the Spevigo (spesolimab) treated patients were free of pustules, ...
22 March 2023 - Today, the Government announced a total investment of up to $1.5 billion over three years in ...
22 March 2023 - Today, the Honourable Jean-Yves Duclos, Minister of Health, announced measures in support of the first-ever National Strategy ...
14 March 2023 - A member of Canada’s drug pricing regulator has resigned, stating the federal government has undermined the ...